{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:58:04Z","timestamp":1783576684112,"version":"3.55.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Non-celiac enteropathies (NCE) can be due to a variety of causes. The workup for NCE includes history, physical, laboratory and histology review and can be difficult. Enteropathies can result in serious illness due to consequences of malabsorption including severe weight loss, nutritional deficiencies, and debilitating diarrhea. Recognition and support of these consequences while investigating underlying etiology is essential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Recent studies in NCEs have focused on improving diagnostic accuracy and predicting long-term outcomes in patients with NCEs. Further, literature has emphasized the importance of histological analysis, with a focus on differentiating between various enteropathies that cause villous atrophy, highlighting the complexity and need for personalized approaches in managing these conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Identification of etiologies of NCEs requires review of patients\u2019 detailed history, medications, and lab results. Common etiologies include immunodeficiencies, infectious, iatrogenic, and malignant causes. Using a systematic approach can lead to proper diagnosis and tailor treatment choices, benefiting patient outcomes. Supportive nutrition care should be initiated early when applicable to minimize morbidity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11894-025-00979-3","type":"journal-article","created":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T23:35:37Z","timestamp":1744587337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Non-celiac Enteropathies"],"prefix":"10.1007","volume":"27","author":[{"given":"Kaitlyn","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scarlett","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"979_CR1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/MOG.0000000000000436","volume":"34","author":"A Schiepatti","year":"2018","unstructured":"Schiepatti A, Sanders DS, Biagi F. Seronegative coeliac disease: clearing the diagnostic dilemma. Curr Opin Gastroenterol. 2018;34:154. https:\/\/doi.org\/10.1097\/MOG.0000000000000436.","journal-title":"Curr Opin Gastroenterol"},{"key":"979_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.mayocp.2017.10.025","volume":"93","author":"CL Jansson-Knodell","year":"2018","unstructured":"Jansson-Knodell CL, Hujoel IA, Rubio-Tapia A, Murray JA. Not all that flattens villi is celiac disease: a review of enteropathies. Mayo Clin Proc. 2018;93:509\u201317. https:\/\/doi.org\/10.1016\/j.mayocp.2017.10.025.","journal-title":"Mayo Clin Proc"},{"key":"979_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1053\/j.gastro.2020.08.061","volume":"160","author":"MM Leonard","year":"2021","unstructured":"Leonard MM, Lebwohl B, Rubio-Tapia A, Biagi F. AGA clinical practice update on the evaluation and management of seronegative enteropathies: expert review. Gastroenterology. 2021;160:437\u201344. https:\/\/doi.org\/10.1053\/j.gastro.2020.08.061.","journal-title":"Gastroenterology"},{"key":"979_CR4","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1136\/gutjnl-2016-312271","volume":"66","author":"I Aziz","year":"2017","unstructured":"Aziz I, Peerally MF, Barnes J-H, Kandasamy V, Whiteley JC, Partridge D, et al. The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000\u20132015). Gut. 2017;66:1563\u201372. https:\/\/doi.org\/10.1136\/gutjnl-2016-312271.","journal-title":"Gut"},{"key":"979_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cgh.2009.12.023","volume":"8","author":"A Rubio-Tapia","year":"2010","unstructured":"Rubio-Tapia A, Talley NJ, Gurudu SR, Wu T-T, Murray JA. Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol. 2010;8:344-349.e3. https:\/\/doi.org\/10.1016\/j.cgh.2009.12.023.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"979_CR6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.gie.2014.10.024","volume":"81","author":"M Latorre","year":"2015","unstructured":"Latorre M, Lagana SM, Freedberg DE, Lewis SK, Lebwohl B, Bhagat G, et al. Endoscopic biopsy technique in the diagnosis of celiac disease: one bite or two? Gastrointest Endosc. 2015;81:1228\u201333. https:\/\/doi.org\/10.1016\/j.gie.2014.10.024.","journal-title":"Gastrointest Endosc"},{"key":"979_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/his.14262","volume":"78","author":"I Brown","year":"2021","unstructured":"Brown I, Bettington M, Rosty C. The role of histopathology in the diagnosis and management of coeliac disease and other malabsorptive conditions. Histopathology. 2021;78:88\u2013105. https:\/\/doi.org\/10.1111\/his.14262.","journal-title":"Histopathology"},{"key":"979_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s11894-012-0276-2","volume":"14","author":"NM Gentile","year":"2012","unstructured":"Gentile NM, Murray JA, Pardi DS. Autoimmune enteropathy: a review and update of clinical management. Curr Gastroenterol Rep. 2012;14:380\u20135. https:\/\/doi.org\/10.1007\/s11894-012-0276-2.","journal-title":"Curr Gastroenterol Rep"},{"key":"979_CR9","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cgh.2007.05.013","volume":"5","author":"S Akram","year":"2007","unstructured":"Akram S, Murray JA, Pardi DS, Alexander GL, Schaffner JA, Russo PA, et al. Adult autoimmune enteropathy: mayo clinic rochester experience. Clin Gastroenterol Hepatol. 2007;5:1282\u201390. https:\/\/doi.org\/10.1016\/j.cgh.2007.05.013.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"979_CR10","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1097\/PAS.0000000000000317","volume":"38","author":"R Masia","year":"2014","unstructured":"Masia R, Peyton S, Lauwers GY, Brown I. Gastrointestinal biopsy findings of autoimmune enteropathy: a review of 25 cases. Am J Surg Pathol. 2014;38:1319. https:\/\/doi.org\/10.1097\/PAS.0000000000000317.","journal-title":"Am J Surg Pathol"},{"key":"979_CR11","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1007\/s10620-020-06540-8","volume":"65","author":"CB Chen","year":"2020","unstructured":"Chen CB, Tahboub F, Plesec T, Kay M, Radhakrishnan K. A review of autoimmune enteropathy and its associated syndromes. Dig Dis Sci. 2020;65:3079\u201390. https:\/\/doi.org\/10.1007\/s10620-020-06540-8.","journal-title":"Dig Dis Sci"},{"key":"979_CR12","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1136\/gut.32.11.1421","volume":"32","author":"IR Sanderson","year":"1991","unstructured":"Sanderson IR, Phillips AD, Spencer J, Walker-Smith JA. Response to autoimmune enteropathy to cyclosporin A therapy. Gut. 1991;32:1421\u20135. https:\/\/doi.org\/10.1136\/gut.32.11.1421.","journal-title":"Gut"},{"key":"979_CR13","doi-asserted-by":"publisher","first-page":"e00387","DOI":"10.14309\/ctg.0000000000000387","volume":"12","author":"RLJ van Wanrooij","year":"2021","unstructured":"van Wanrooij RLJ, Neefjes-Borst EA, Bontkes HJ, Schreurs MWJ, Langerak AW, Mulder CJJ, et al. Adult-onset autoimmune enteropathy in an European tertiary referral center. Clin Transl Gastroenterol. 2021;12:e00387. https:\/\/doi.org\/10.14309\/ctg.0000000000000387.","journal-title":"Clin Transl Gastroenterol"},{"key":"979_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13062-020-00280-5","volume":"15","author":"L Petagna","year":"2020","unstructured":"Petagna L, Antonelli A, Ganini C, Bellato V, Campanelli M, Divizia A, et al. Pathophysiology of Crohn\u2019s disease inflammation and recurrence. Biol Direct. 2020;15:23. https:\/\/doi.org\/10.1186\/s13062-020-00280-5.","journal-title":"Biol Direct"},{"key":"979_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/ncpgasthep0528","volume":"3","author":"RB Sartor","year":"2006","unstructured":"Sartor RB. Mechanisms of Disease: pathogenesis of Crohn\u2019s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3:390\u2013407. https:\/\/doi.org\/10.1038\/ncpgasthep0528.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"979_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3978\/j.issn.2305-5839.2015.01.02","volume":"3","author":"C Dai","year":"2015","unstructured":"Dai C, Jiang M, Sun M-J. Innate immunity and adaptive immunity in Crohn\u2019s disease. Ann Transl Med. 2015;3:34\u201334. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.01.02.","journal-title":"Ann Transl Med"},{"key":"979_CR17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1053\/gast.1996.v111.pm8780560","volume":"111","author":"JM Polito","year":"1996","unstructured":"Polito JM, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM. Crohn\u2019s disease: Influence of age at diagnosis on site and clinical type of disease. Gastroenterology. 1996;111:580\u20136. https:\/\/doi.org\/10.1053\/gast.1996.v111.pm8780560.","journal-title":"Gastroenterology"},{"key":"979_CR18","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","volume":"389","author":"J Torres","year":"2017","unstructured":"Torres J, Mehandru S, Colombel J-F, Peyrin-Biroulet L. Crohn\u2019s disease. The Lancet. 2017;389:1741\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(16)31711-1.","journal-title":"The Lancet"},{"key":"979_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ajg.2018.27","volume":"113","author":"GR Lichtenstein","year":"2018","unstructured":"Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: Management of crohn\u2019s disease in adults. Off J Am Coll Gastroenterol ACG. 2018;113:481. https:\/\/doi.org\/10.1038\/ajg.2018.27.","journal-title":"Off J Am Coll Gastroenterol ACG"},{"key":"979_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.21037\/dmr-21-1","volume":"4","author":"L Kellermann","year":"2021","unstructured":"Kellermann L, Riis LB. A close view on histopathological changes in inflammatory bowel disease, a narrative review. Dig Med Res. 2021;4:33. https:\/\/doi.org\/10.21037\/dmr-21-1.","journal-title":"Dig Med Res"},{"key":"979_CR21","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","volume":"403","author":"M Dolinger","year":"2024","unstructured":"Dolinger M, Torres J, Vermeire S. Crohn\u2019s disease. The Lancet. 2024;403:1177\u201391. https:\/\/doi.org\/10.1016\/S0140-6736(23)02586-2.","journal-title":"The Lancet"},{"key":"979_CR22","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.cgh.2006.07.003","volume":"4","author":"S Daum","year":"2006","unstructured":"Daum S, Foss H-D, Schuppan D, Riecken E-O, Zeitz M, Ullrich R. Synthesis of collagen I in collagenous sprue. Clin Gastroenterol Hepatol. 2006;4:1232\u20136. https:\/\/doi.org\/10.1016\/j.cgh.2006.07.003.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"979_CR23","first-page":"418","volume":"5","author":"Z Xiao","year":"2009","unstructured":"Xiao Z, Dasari VM, Kirby DF, Bronner M, Plesec TP, Lashner BA. Collagenous sprue. Gastroenterol Hepatol. 2009;5:418\u201324.","journal-title":"Gastroenterol Hepatol"},{"key":"979_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.5858\/2010-0028-RS.1","volume":"135","author":"X Zhao","year":"2011","unstructured":"Zhao X, Johnson RL. Collagenous sprue: a rare, severe small-bowel malabsorptive disorder. Arch Pathol Lab Med. 2011;135:803\u20139. https:\/\/doi.org\/10.5858\/2010-0028-RS.1.","journal-title":"Arch Pathol Lab Med"},{"key":"979_CR25","doi-asserted-by":"publisher","first-page":"821976","DOI":"10.1155\/2011\/821976","volume":"25","author":"HJ Freeman","year":"2011","unstructured":"Freeman HJ. Collagenous sprue. Can J Gastroenterol Hepatol. 2011;25:821976. https:\/\/doi.org\/10.1155\/2011\/821976.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"979_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3748\/wjg.v16.i3.296","volume":"16","author":"HJ Freeman","year":"2010","unstructured":"Freeman HJ. Update on collagenous sprue. World J Gastroenterol. 2010;16:296\u20138. https:\/\/doi.org\/10.3748\/wjg.v16.i3.296.","journal-title":"World J Gastroenterol"},{"key":"979_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/2050640620951905","volume":"9","author":"S Miehlke","year":"2021","unstructured":"Miehlke S, Guagnozzi D, Zabana Y, Tontini GE, Kanstrup Fiehn A-M, Wildt S, et al. European guidelines on microscopic colitis: United European gastroenterology and European microscopic colitis group statements and recommendations. United Eur Gastroenterol J. 2021;9:13\u201337. https:\/\/doi.org\/10.1177\/2050640620951905.","journal-title":"United Eur Gastroenterol J"},{"key":"979_CR28","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1055\/s-0028-1109057","volume":"47","author":"C Schmidt","year":"2009","unstructured":"Schmidt C, Kasim E, Schlake W, Gerken G, Giese T, Stallmach A. TNF-alpha antibody treatment in refractory collagenous sprue: report of a case and review of the literature. Z Gastroenterol. 2009;47:575\u20138. https:\/\/doi.org\/10.1055\/s-0028-1109057.","journal-title":"Z Gastroenterol"},{"key":"979_CR29","doi-asserted-by":"publisher","first-page":"6928","DOI":"10.3748\/wjg.v19.i40.6928","volume":"19","author":"JA Nielsen","year":"2013","unstructured":"Nielsen JA, Steephen A, Lewin M. Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug. World J Gastroenterol. 2013;19:6928\u201330. https:\/\/doi.org\/10.3748\/wjg.v19.i40.6928.","journal-title":"World J Gastroenterol"},{"key":"979_CR30","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.mayocp.2012.06.003","volume":"87","author":"A Rubio-Tapia","year":"2012","unstructured":"Rubio-Tapia A, Herman ML, Ludvigsson JF, Kelly DG, Mangan TF, Wu T-T, et al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc. 2012;87:732\u20138. https:\/\/doi.org\/10.1016\/j.mayocp.2012.06.003.","journal-title":"Mayo Clin Proc"},{"key":"979_CR31","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.dld.2016.05.024","volume":"48","author":"U Volta","year":"2016","unstructured":"Volta U, Caio G, Boschetti E, Giancola F, Rhoden KJ, Ruggeri E, et al. Seronegative celiac disease: Shedding light on an obscure clinical entity. Dig Liver Dis. 2016;48:1018\u201322. https:\/\/doi.org\/10.1016\/j.dld.2016.05.024.","journal-title":"Dig Liver Dis"},{"key":"979_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.gastha.2023.08.014","volume":"3","author":"AK Cartee","year":"2024","unstructured":"Cartee AK, Beasley TM, Estes D, Herman TT, Morgan DR. Black patients are more likely to have negative serologies with celiac consistent histology in a southeast US tertiary Center. Gastro Hep Adv. 2024;3:4\u20136. https:\/\/doi.org\/10.1016\/j.gastha.2023.08.014.","journal-title":"Gastro Hep Adv"},{"key":"979_CR33","first-page":"110","volume":"8","author":"E Ierardi","year":"2015","unstructured":"Ierardi E, Losurdo G, Piscitelli D, Giorgio F, Sorrentino C, Principi M, et al. Seronegative celiac disease: where is the specific setting? Gastroenterol Hepatol Bed Bench. 2015;8:110\u20136.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"979_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.molmed.2012.04.007","volume":"18","author":"PS Korpe","year":"2012","unstructured":"Korpe PS, Petri WA. Environmental enteropathy: Critical implications of a poorly understood condition. Trends Mol Med. 2012;18:328\u201336. https:\/\/doi.org\/10.1016\/j.molmed.2012.04.007.","journal-title":"Trends Mol Med"},{"key":"979_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000314231","volume":"4","author":"MJ Batheja","year":"2010","unstructured":"Batheja MJ, Leighton J, Azueta A, Heigh R. The face of tropical sprue in 2010. Case Rep Gastroenterol. 2010;4:168\u201372. https:\/\/doi.org\/10.1159\/000314231.","journal-title":"Case Rep Gastroenterol"},{"key":"979_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1051\/parasite\/2008153261","volume":"15","author":"AG Buret","year":"2008","unstructured":"Buret AG. Pathophysiology of enteric infections with Giardia duodenalius. Parasite Paris Fr. 2008;15:261\u20135. https:\/\/doi.org\/10.1051\/parasite\/2008153261.","journal-title":"Parasite Paris Fr"},{"key":"979_CR37","volume-title":"Giardiasis","author":"N Dunn","year":"2024","unstructured":"Dunn N, Juergens AL. Giardiasis. StatPearls: StatPearls Publishing; 2024."},{"key":"979_CR38","volume-title":"Whipple Disease","author":"C Antunes","year":"2024","unstructured":"Antunes C, Singhal M. Whipple Disease. StatPearls: StatPearls Publishing; 2024."},{"key":"979_CR39","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1007\/BF02087770","volume":"39","author":"GE Feurle","year":"1994","unstructured":"Feurle GE, Marth T. An evaluation of antimicrobial treatment for Whipple\u2019s Disease. Tetracycline versus trimethoprim-sulfamethoxazole. Dig Dis Sci. 1994;39:1642\u20138. https:\/\/doi.org\/10.1007\/BF02087770.","journal-title":"Dig Dis Sci"},{"key":"979_CR40","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.3748\/wjg.v25.i37.5578","volume":"25","author":"BB de Brito","year":"2019","unstructured":"de Brito BB, da Silva FAF, Soares AS, Pereira VA, Santos MLC, Sampaio MM, et al. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J Gastroenterol. 2019;25:5578\u201389. https:\/\/doi.org\/10.3748\/wjg.v25.i37.5578.","journal-title":"World J Gastroenterol"},{"key":"979_CR41","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/modpathol.3800404","volume":"18","author":"L Memeo","year":"2005","unstructured":"Memeo L, Jhang J, Hibshoosh H, Green PH, Rotterdam H, Bhagat G. Duodenal intraepithelial lymphocytosis with normal villous architecture: common occurrence in H. pylori gastritis. Mod Pathol. 2005;18:1134\u201344. https:\/\/doi.org\/10.1038\/modpathol.3800404.","journal-title":"Mod Pathol"},{"key":"979_CR42","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1053\/j.gastro.2020.11.059","volume":"160","author":"SC Shah","year":"2021","unstructured":"Shah SC, Iyer PG, Moss SF. AGA clinical practice update on the management of refractory helicobacter pylori infection: expert review. Gastroenterology. 2021;160:1831\u201341. https:\/\/doi.org\/10.1053\/j.gastro.2020.11.059.","journal-title":"Gastroenterology"},{"key":"979_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4046\/trd.2015.78.2.47","volume":"78","author":"JY Lee","year":"2015","unstructured":"Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis. 2015;78:47\u201355. https:\/\/doi.org\/10.4046\/trd.2015.78.2.47.","journal-title":"Tuberc Respir Dis"},{"key":"979_CR44","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1086\/605559","volume":"49","author":"HM Peto","year":"2009","unstructured":"Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993\u20132006. Clin Infect Dis. 2009;49:1350\u20137. https:\/\/doi.org\/10.1086\/605559.","journal-title":"Clin Infect Dis"},{"key":"979_CR45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5217\/ir.2017.15.2.187","volume":"15","author":"S Kumar","year":"2017","unstructured":"Kumar S, Bopanna S, Kedia S, Mouli P, Dhingra R, Padhan R, et al. Evaluation of Xpert MTB\/RIF assay performance in the diagnosis of abdominal tuberculosis. Intest Res. 2017;15:187\u201394. https:\/\/doi.org\/10.5217\/ir.2017.15.2.187.","journal-title":"Intest Res"},{"key":"979_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7326\/0003-4819-79-1-18","volume":"79","author":"SG Agus","year":"1973","unstructured":"Agus SG, Dolin R, Wyatt RG, Tousimis AJ, Northrup RS. Acute infectious nonbacterial gastroenteritis: intestinal histopathology. Ann Intern Med. 1973;79:18\u201325. https:\/\/doi.org\/10.7326\/0003-4819-79-1-18.","journal-title":"Ann Intern Med"},{"key":"979_CR47","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.gtc.2012.06.009","volume":"41","author":"E Krones","year":"2012","unstructured":"Krones E, H\u00f6genauer C. Diarrhea in the immunocompromised patient. Gastroenterol Clin North Am. 2012;41:677\u2013701. https:\/\/doi.org\/10.1016\/j.gtc.2012.06.009.","journal-title":"Gastroenterol Clin North Am"},{"key":"979_CR48","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ajg.2014.432","volume":"110","author":"JM Woodward","year":"2015","unstructured":"Woodward JM, Gkrania-Klotsas E, Cordero-Ng AY, Aravinthan A, Bandoh BN, Liu H, et al. The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency. Am J Gastroenterol. 2015;110:320\u20137. https:\/\/doi.org\/10.1038\/ajg.2014.432.","journal-title":"Am J Gastroenterol"},{"key":"979_CR49","doi-asserted-by":"publisher","first-page":"e241752","DOI":"10.1136\/bcr-2021-241752","volume":"14","author":"P Jain","year":"2021","unstructured":"Jain P, Mishra A, Gupta D, Kulkarni S. Chronic enteropathy-related malabsorption syndrome in an adult with common variable immunodeficiency and symptomatic norovirus infection of the gut. BMJ Case Rep. 2021;14:e241752. https:\/\/doi.org\/10.1136\/bcr-2021-241752.","journal-title":"BMJ Case Rep"},{"key":"979_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijid.2023.11.037","volume":"139","author":"MS Kapembwa","year":"2024","unstructured":"Kapembwa MS, Batman PA, Fleming SC, Griffin GE. HIV enteropathy and \u2018Slim disease\u2019: Historical and current perspectives. Int J Infect Dis. 2024;139:86\u201391. https:\/\/doi.org\/10.1016\/j.ijid.2023.11.037.","journal-title":"Int J Infect Dis"},{"key":"979_CR51","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/cid\/cis544","volume":"55","author":"RD MacArthur","year":"2012","unstructured":"MacArthur RD, DuPont HL. Etiology and pharmacologic management of noninfectious diarrhea in HIV-infected individuals in the highly active antiretroviral therapy era. Clin Infect Dis. 2012;55:860\u20137. https:\/\/doi.org\/10.1093\/cid\/cis544.","journal-title":"Clin Infect Dis"},{"key":"979_CR52","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.3748\/wjg.v16.i24.2978","volume":"16","author":"J Bures","year":"2010","unstructured":"Bures J, Cyrany J, Kohoutova D, F\u00f6rstl M, Rejchrt S, Kvetina J, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol WJG. 2010;16:2978\u201390. https:\/\/doi.org\/10.3748\/wjg.v16.i24.2978.","journal-title":"World J Gastroenterol WJG"},{"key":"979_CR53","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1043\/1543-2165-134.2.264","volume":"134","author":"PJ Lappinga","year":"2010","unstructured":"Lappinga PJ, Abraham SC, Murray JA, Vetter EA, Patel R, Wu T-T. Small intestinal bacterial overgrowth: histopathologic features and clinical correlates in an underrecognized entity. Arch Pathol Lab Med. 2010;134:264\u201370. https:\/\/doi.org\/10.1043\/1543-2165-134.2.264.","journal-title":"Arch Pathol Lab Med"},{"key":"979_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/apt.12780","volume":"40","author":"G Ianiro","year":"2014","unstructured":"Ianiro G, Bibb\u00f2 S, Montalto M, Ricci R, Gasbarrini A, Cammarota G. Systematic review: sprue-like enteropathy associated with olmesartan. Aliment Pharmacol Ther. 2014;40:16\u201323. https:\/\/doi.org\/10.1111\/apt.12780.","journal-title":"Aliment Pharmacol Ther"},{"key":"979_CR55","doi-asserted-by":"publisher","first-page":"49","DOI":"10.12691\/ijcd-2-2-5","volume":"2","author":"HJ Freeman","year":"2014","unstructured":"Freeman HJ. Drug-induced sprue-like intestinal disease. Int J Celiac Dis. 2014;2:49\u201353.","journal-title":"Int J Celiac Dis"},{"key":"979_CR56","doi-asserted-by":"publisher","first-page":"446","DOI":"10.5217\/ir.2017.15.4.446","volume":"15","author":"SJ Shin","year":"2017","unstructured":"Shin SJ, Noh C-K, Lim SG, Lee KM, Lee KJ. Non-steroidal anti-inflammatory drug-induced enteropathy. Intest Res. 2017;15:446\u201355. https:\/\/doi.org\/10.5217\/ir.2017.15.4.446.","journal-title":"Intest Res"},{"key":"979_CR57","doi-asserted-by":"publisher","first-page":"2022-6-3","DOI":"10.7573\/dic.2022-6-3","volume":"11","author":"A Schiepatti","year":"2022","unstructured":"Schiepatti A, Premoli A, Maimaris S, Rizzo M, Marples M, Villani L, et al. Small bowel villous atrophy due to immune-checkpoint inhibitors: report of two cases and literature review. Drugs Context. 2022;11:2022-6\u20133. https:\/\/doi.org\/10.7573\/dic.2022-6-3.","journal-title":"Drugs Context"},{"key":"979_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-024-01167-8","volume":"14","author":"GG Fortuna","year":"2024","unstructured":"Fortuna GG, Banerjee R, Savid-Frontera C, Song J, Mor\u00e1n-Segura CM, Nguyen JV, et al. Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma. Blood Cancer J. 2024;14:1\u20138. https:\/\/doi.org\/10.1038\/s41408-024-01167-8.","journal-title":"Blood Cancer J"},{"key":"979_CR59","doi-asserted-by":"publisher","first-page":"175883592413098","DOI":"10.1177\/17588359241309825","volume":"16","author":"K Ye","year":"2024","unstructured":"Ye K, Yu C, Shen Z. Severe refractory colitis after intraperitoneal infusion of CEA-directed CAR T cells in patients with colorectal cancer. Ther Adv Med Oncol. 2024;16:17588359241309824. https:\/\/doi.org\/10.1177\/17588359241309825.","journal-title":"Ther Adv Med Oncol"},{"key":"979_CR60","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/ibd\/izaa320","volume":"27","author":"A Hashim","year":"2021","unstructured":"Hashim A, Patten PEM, Kuhnl A, Ooft ML, Hayee B, Sanderson R. Colitis after CAR T-cell therapy for refractory large B-cell lymphoma responds to anti-integrin therapy. Inflamm Bowel Dis. 2021;27:e45\u20136. https:\/\/doi.org\/10.1093\/ibd\/izaa320.","journal-title":"Inflamm Bowel Dis"},{"key":"979_CR61","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1445-5994.1982.tb02476.x","volume":"12","author":"AO Kwitko","year":"1982","unstructured":"Kwitko AO, Pieterse AS, Hecker R, Rowland R, Wigg DR. Chronic radiation injury to the intestine: a clinico-pathological study. Aust N Z J Med. 1982;12:272\u20137. https:\/\/doi.org\/10.1111\/j.1445-5994.1982.tb02476.x.","journal-title":"Aust N Z J Med"},{"key":"979_CR62","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1365-2559.1985.tb02833.x","volume":"9","author":"PS Hasleton","year":"1985","unstructured":"Hasleton PS, Carr N, Schofield PF. Vascular changes in radiation bowel disease. Histopathology. 1985;9:517\u201334. https:\/\/doi.org\/10.1111\/j.1365-2559.1985.tb02833.x.","journal-title":"Histopathology"},{"key":"979_CR63","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.3748\/wjg.v13.i26.3610","volume":"13","author":"A Larsen","year":"2007","unstructured":"Larsen A, Reitan JB, Aase ST, Hauer-Jensen M. Long-term prognosis in patients with severe late radiation enteropathy: A prospective cohort study. World J Gastroenterol WJG. 2007;13:3610\u20133. https:\/\/doi.org\/10.3748\/wjg.v13.i26.3610.","journal-title":"World J Gastroenterol WJG"},{"key":"979_CR64","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1309\/nw2bk1dxb0eqg55h","volume":"127","author":"A Zettl","year":"2007","unstructured":"Zettl A, deLeeuw R, Haralambieva E, Mueller-Hermelink H-K. Enteropathy-type T-cell lymphoma. Am J Clin Pathol. 2007;127:701\u20136. https:\/\/doi.org\/10.1309\/nw2bk1dxb0eqg55h.","journal-title":"Am J Clin Pathol"},{"key":"979_CR65","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","volume":"118","author":"J Delabie","year":"2011","unstructured":"Delabie J, Holte H, Vose JM, Ullrich F, Jaffe ES, Savage KJ, et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood. 2011;118:148\u201355. https:\/\/doi.org\/10.1182\/blood-2011-02-335216.","journal-title":"Blood"},{"key":"979_CR66","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","volume":"136","author":"FA Bonilla","year":"2015","unstructured":"Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136:1186-1205.e1-78. https:\/\/doi.org\/10.1016\/j.jaci.2015.04.049.","journal-title":"J Allergy Clin Immunol"},{"key":"979_CR67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11894-016-0491-3","volume":"18","author":"M Uzzan","year":"2016","unstructured":"Uzzan M, Ko HM, Mehandru S, Cunningham-Rundles C. Gastrointestinal disorders associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD). Curr Gastroenterol Rep. 2016;18:17. https:\/\/doi.org\/10.1007\/s11894-016-0491-3.","journal-title":"Curr Gastroenterol Rep"},{"key":"979_CR68","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1080\/00365521.2019.1568543","volume":"54","author":"MV Pensieri","year":"2019","unstructured":"Pensieri MV, Pulvirenti F, Schiepatti A, Maimaris S, Lattanzio S, Quinti I, et al. The high mortality of patients with common variable immunodeficiency and small bowel villous atrophy. Scand J Gastroenterol. 2019;54:164\u20138. https:\/\/doi.org\/10.1080\/00365521.2019.1568543.","journal-title":"Scand J Gastroenterol"},{"key":"979_CR69","doi-asserted-by":"publisher","first-page":"648","DOI":"10.14309\/ajg.0000000000000140","volume":"114","author":"S Pikkarainen","year":"2019","unstructured":"Pikkarainen S, Martelius T, Ristim\u00e4ki A, Siitonen S, Sepp\u00e4nen MRJ, F\u00e4rkkil\u00e4 M. A high prevalence of gastrointestinal manifestations in common variable immunodeficiency. Am J Gastroenterol. 2019;114:648\u201355. https:\/\/doi.org\/10.14309\/ajg.0000000000000140.","journal-title":"Am J Gastroenterol"},{"key":"979_CR70","doi-asserted-by":"publisher","unstructured":"Franzblau LE, Fuleihan RL, Cunningham-Rundles C, Wysocki CA. CVID-associated intestinal disorders in the USIDNET registry: An analysis of disease manifestations, functional status, comorbidities, and treatment. Res Sq. 2023;rs.3.rs-2838051. https:\/\/doi.org\/10.21203\/rs.3.rs-2838051\/v1.","DOI":"10.21203\/rs.3.rs-2838051\/v1"},{"key":"979_CR71","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1097\/PAS.0b013e3180cab60c","volume":"31","author":"JA Daniels","year":"2007","unstructured":"Daniels JA, Lederman HM, Maitra A, Montgomery EA. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007;31:1800\u201312. https:\/\/doi.org\/10.1097\/PAS.0b013e3180cab60c.","journal-title":"Am J Surg Pathol"},{"key":"979_CR72","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1365-2249.2007.03481.x","volume":"150","author":"I Chua","year":"2007","unstructured":"Chua I, Standish R, Lear S, Harbord M, Eren E, Raeiszadeh M, et al. Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID). Clin Exp Immunol. 2007;150:306\u201311. https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03481.x.","journal-title":"Clin Exp Immunol"},{"key":"979_CR73","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/ajg.2017.246","volume":"112","author":"BS Boland","year":"2017","unstructured":"Boland BS, Riedl MA, Valasek MA, Crowe SE, Sandborn WJ. Vedolizumab in patients with common variable immune deficiency (CVID) and gut inflammation. Am J Gastroenterol. 2017;112:1621. https:\/\/doi.org\/10.1038\/ajg.2017.246.","journal-title":"Am J Gastroenterol"},{"key":"979_CR74","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000486448","volume":"25","author":"C Arieira","year":"2018","unstructured":"Arieira C, Dias de Castro F, Moreira MJ, Cotter J. Common variable immunodeficiency-associated inflammatory enteropathy: the new era of biological therapy. GE Port J Gastroenterol. 2018;25:322\u20136. https:\/\/doi.org\/10.1159\/000486448.","journal-title":"GE Port J Gastroenterol"},{"key":"979_CR75","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1093\/ibd\/izaa012","volume":"26","author":"HJ Akhtar","year":"2020","unstructured":"Akhtar HJ, Markandey B, Ma C, Ramsewak D, Walsh JC, Jairath V. Vedolizumab induced clinical, endoscopic, and histological improvement in common variable immunodeficiency disease-associated intestinal enteropathy. Inflamm Bowel Dis. 2020;26:e22\u20133. https:\/\/doi.org\/10.1093\/ibd\/izaa012.","journal-title":"Inflamm Bowel Dis"},{"key":"979_CR76","doi-asserted-by":"publisher","first-page":"108362","DOI":"10.1016\/j.clim.2020.108362","volume":"212","author":"T Sifers","year":"2020","unstructured":"Sifers T, Hirten R, Mehandru S, Ko HM, Colombel J-F, Cunningham-Rundles C. Vedolizumab therapy in common variable immune deficiency associated enteropathy: A case series. Clin Immunol Orlando Fla. 2020;212:108362. https:\/\/doi.org\/10.1016\/j.clim.2020.108362.","journal-title":"Clin Immunol Orlando Fla"},{"key":"979_CR77","doi-asserted-by":"publisher","first-page":"e00721","DOI":"10.14309\/crj.0000000000000721","volume":"9","author":"D Johnson","year":"2021","unstructured":"Johnson D, Lee G, Weber F. Vedolizumab therapy in refractory enteropathy associated with CVID. ACG Case Rep J. 2021;9:e00721. https:\/\/doi.org\/10.14309\/crj.0000000000000721.","journal-title":"ACG Case Rep J"},{"key":"979_CR78","doi-asserted-by":"publisher","first-page":"4","DOI":"10.17235\/reed.2023.10032\/2023","volume":"5","author":"R Quera","year":"2023","unstructured":"Quera R, N\u00fa\u00f1ez Figueroa P, Za\u00f1artu P, Contreras L. Effectiveness of infliximab in common variable immunodeficiency associated with enteropathy. Rev Esp Enferm Dig. 2023;5:4. https:\/\/doi.org\/10.17235\/reed.2023.10032\/2023.","journal-title":"Rev Esp Enferm Dig"},{"key":"979_CR79","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1067\/mpd.2002.127663","volume":"141","author":"JR Guajardo","year":"2002","unstructured":"Guajardo JR, Plotnick LM, Fende JM, Collins MH, Putnam PE, Rothenberg ME. Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry. J Pediatr. 2002;141:576\u201381. https:\/\/doi.org\/10.1067\/mpd.2002.127663.","journal-title":"J Pediatr"},{"key":"979_CR80","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/MPG.0000000000000865","volume":"62","author":"ET Jensen","year":"2016","unstructured":"Jensen ET, Martin CF, Kappelman MD, Dellon ES. Prevalence of Eosinophilic gastritis, gastroenteritis, and colitis: Estimates from a national administrative database. J Pediatr Gastroenterol Nutr. 2016;62:36\u201342. https:\/\/doi.org\/10.1097\/MPG.0000000000000865.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"979_CR81","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.cgh.2017.05.050","volume":"15","author":"E Mansoor","year":"2017","unstructured":"Mansoor E, Saleh MA, Cooper GS. Prevalence of eosinophilic gastroenteritis and colitis in a population-based study, From 2012 to 2017. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2017;15:1733\u201341. https:\/\/doi.org\/10.1016\/j.cgh.2017.05.050.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"979_CR82","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jaci.2019.11.007","volume":"145","author":"T Shoda","year":"2020","unstructured":"Shoda T, Wen T, Caldwell JM, Collins MH, Besse JA, Osswald GA, et al. Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study. J Allergy Clin Immunol. 2020;145:255\u201369. https:\/\/doi.org\/10.1016\/j.jaci.2019.11.007.","journal-title":"J Allergy Clin Immunol"},{"key":"979_CR83","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/MPG.0000000000000766","volume":"61","author":"AJ Lucendo","year":"2015","unstructured":"Lucendo AJ, Serrano-Montalb\u00e1n B, Arias \u00c1, Redondo O, Tenias JM. Efficacy of dietary treatment for inducing disease remission in eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr. 2015;61:56\u201364. https:\/\/doi.org\/10.1097\/MPG.0000000000000766.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"979_CR84","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.iac.2024.01.010","volume":"44","author":"ES Dellon","year":"2024","unstructured":"Dellon ES, Gupta SK. Pharmacologic management of non-eosinophilic esophagitis eosinophilic gastrointestinal diseases. Immunol Allergy Clin North Am. 2024;44:397\u2013406. https:\/\/doi.org\/10.1016\/j.iac.2024.01.010.","journal-title":"Immunol Allergy Clin North Am"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-00979-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-025-00979-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-00979-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:02:48Z","timestamp":1772578968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-025-00979-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["979"],"URL":"https:\/\/doi.org\/10.1007\/s11894-025-00979-3","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"2 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"27"}}